Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis

被引：55
|
作者：
Mildiner, Sorcha [1 ]
Malnick, Stephen [1 ]
机构：
[1] Kaplan Med Ctr, Rehovot, Israel
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 376卷 / 17期
关键词：
D O I：
10.1056/NEJMc1702076
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1692 / 1693
页数：2
相关论文
共 50 条
  • [21] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Chognot, C.
    Jessop, N.
    Pradhan, A.
    Prajapati, K.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 607 - 608
  • [22] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis
    Kappos, Ludwig
    Hauser, Stephen
    Montalban, Xavier
    Buffels, Regine
    Chin, Peter
    Li, Carrie
    Mortensen, Deborah
    Napieralski, Julie
    Van Beek, Johan
    Wormser, David
    Wolinsky, Jerry
    NEUROLOGY, 2017, 88
  • [23] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S.
    Kappos, L.
    Montalban, X.
    Craveiro, L.
    Hughes, R.
    McNamara, J.
    Pradhan, A.
    Wormser, D.
    Koendgen, H.
    Wolinsky, J. S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [24] Effect of Ocrelizumab on Thalamic Atrophy in Patients with Relapsing and Primary Progressive Multiple Sclerosis
    Arnold, Douglas L.
    Sprenger, Till
    Bar-Or, Amit
    Wolinsky, Jerry S.
    Kappos, Ludwig
    Kolind, Shannon
    Manfrini, Marianna
    Magon, Stefano
    van Beek, Johan
    Koendgen, Harold
    Bernasconi, Corrado
    Gaetano, Laura
    Traboulsee, Anthony
    NEUROLOGY, 2020, 94 (15)
  • [25] Ocrelizumab for primary progressive multiple sclerosis
    Adler, Ai
    Knight, H.
    LANCET NEUROLOGY, 2019, 18 (09): : 816 - 817
  • [26] Ocrelizumab for primary progressive multiple sclerosis
    Montalban X
    Hauser SL
    Kappos L
    中华物理医学与康复杂志, 2017, (03) : 174 - 174
  • [27] Reduction of intrathecal immunoglobulin levels with ocrelizumab treatment in relapsing and primary progressive multiple sclerosis
    Weber, Martin
    Gelfand, Jeffrey
    Bar-Or, Amit
    Cameron, Briana
    Ramesh, Akshaya
    Anania, Veronica
    von Budingen, H. -Christian
    Herman, Ann
    Spiciarich, David
    Grondey, Katja
    Schuetz, Konstantin
    Winger, Ryan
    Jia, Xiaoming
    Harp, Christopher
    Cross, Anne
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 570 - 571
  • [28] Relapsing-remitting and primary progressive multiple sclerosis treated with ocrelizumab: A comparative study
    de Antonio, Luis A. Rodriguez
    Cuberta-Gonzalez, Ines
    Garcia-Castanon, Inmaculada
    Oreja-Guevara, Celia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 69
  • [29] Real world evidence with Ocrelizumab in progressive and relapsing multiple sclerosis
    Meca-Lallana, V.
    Diaz-Perez, C.
    Aguirre, C.
    del Rio, B.
    Martin, R.
    del Rio, B.
    Carabajal, E.
    Vivancos, J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 97 - 98
  • [30] Beyond ocrelizumab in primary progressive multiple sclerosis
    Thomas Williams
    Jeremy Chataway
    Nature Reviews Neurology, 2022, 18 : 641 - 642
12345